ATE344049T1 - Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes - Google Patents

Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes

Info

Publication number
ATE344049T1
ATE344049T1 AT02745850T AT02745850T ATE344049T1 AT E344049 T1 ATE344049 T1 AT E344049T1 AT 02745850 T AT02745850 T AT 02745850T AT 02745850 T AT02745850 T AT 02745850T AT E344049 T1 ATE344049 T1 AT E344049T1
Authority
AT
Austria
Prior art keywords
active ingredient
cyanidine
glycoside
diabetes
medicine containing
Prior art date
Application number
AT02745850T
Other languages
English (en)
Inventor
Takanori Tsuda
Fumihiko Horio
Toshihiko Osawa
Koji Uchida
Hiromitsu Aoki
Takatoshi Koda
Original Assignee
San Ei Gen Ffi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by San Ei Gen Ffi Inc filed Critical San Ei Gen Ffi Inc
Application granted granted Critical
Publication of ATE344049T1 publication Critical patent/ATE344049T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
AT02745850T 2002-02-28 2002-07-04 Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes ATE344049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002054286A JP2003252766A (ja) 2002-02-28 2002-02-28 シアニジン３−グルコシドを有効成分とする抗肥満及び／又は抗糖尿病剤

Publications (1)

Publication Number Publication Date
ATE344049T1 true ATE344049T1 (de) 2006-11-15

Family

ID=27764391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02745850T ATE344049T1 (de) 2002-02-28 2002-07-04 Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes

Country Status (9)

Country Link
US (1) US20050084548A1 (de)
EP (1) EP1480663B1 (de)
JP (1) JP2003252766A (de)
AT (1) ATE344049T1 (de)
AU (1) AU2002317501A1 (de)
CA (1) CA2477555A1 (de)
DE (1) DE60215866T2 (de)
ES (1) ES2274053T3 (de)
WO (1) WO2003072121A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1602652A1 (de) * 2003-03-03 2005-12-07 San-Ei Gen F.F.I., Inc. Promoter für die expression von adiponectin
WO2005040182A1 (ja) * 2003-10-24 2005-05-06 Meiji Seika Kaisha, Ltd. 後期糖化最終生成物形成の新規阻害剤及びアルドース還元酵素阻害剤
WO2005082390A1 (ja) * 2004-03-02 2005-09-09 Asahi Breweries, Ltd. 脂肪蓄積抑制剤
JP4247833B2 (ja) * 2004-03-16 2009-04-02 株式会社ケーツーコミュニケーションズ 視機能改善剤
US20070244202A1 (en) * 2004-06-28 2007-10-18 Kao Corporation Ampk Activator
US7737121B2 (en) * 2004-07-29 2010-06-15 Board Of Trustees Of Michigan State University Insulin secretion by anthocyanins and anthocyanidins
US7772195B2 (en) * 2004-07-29 2010-08-10 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
JP5111725B2 (ja) * 2004-10-21 2013-01-09 株式会社 バイオセラピー開発研究センター スイゼンジナを用いた医薬組成物
JP5118292B2 (ja) * 2005-06-16 2013-01-16 株式会社ロッテ 脂肪分解促進剤
US20070054965A1 (en) * 2005-09-05 2007-03-08 Kao Corporation AMPK activating agent
ITRM20060233A1 (it) * 2006-04-28 2007-10-29 Angela Maria Amorini Metodo per la preparazione e l uso di un estratto arricchito in cianidina 3 o beta glucopiranoside e suoi derivati da frutti e vegetali conenti detta antocianina e per la purificazione e l uso di cianidina 3 o beta glucopiranoside e suoi derivati da
JP5201662B2 (ja) * 2007-02-28 2013-06-05 キッコーマン株式会社 血流改善組成物
US20090176718A1 (en) * 2007-10-31 2009-07-09 David Ribnicky Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome
FI20095144A0 (fi) * 2009-02-17 2009-02-17 Danisco Sugar Oy Elintarvikevalmiste
JP6105186B2 (ja) * 2009-04-22 2017-03-29 株式会社ブルボン 膵リパーゼ阻害剤
CN101933919B (zh) * 2010-07-01 2012-04-18 北京世纪博康医药科技有限公司 棕矢车菊素的用途
KR101322503B1 (ko) * 2010-10-11 2013-11-13 강원대학교산학협력단 맥문동 종자 추출물을 포함하는 항비만 조성물
KR101309137B1 (ko) 2011-08-30 2013-09-17 가톨릭대학교 산학협력단 Ｃ３ｇ 또는 이를 함유하는 오디 추출물을 포함하는 당뇨병성 발기부전의 예방 또는 치료용 조성물
JP2016175842A (ja) * 2013-08-12 2016-10-06 オリザ油化株式会社 Ｇｈｇ含有組成物及びそれを用いた脂肪吸収抑制剤
JP6364362B2 (ja) * 2015-02-17 2018-07-25 学校法人福岡大学 ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法
CN114081893A (zh) * 2021-10-11 2022-02-25 暨南大学 花色苷和果胶联用在制备预防和/或治疗非酒精性脂肪肝药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229439A (en) * 1977-11-21 1980-10-21 Societe De Recherches Industrielles (Sori) Method of treatment of atheroma
JP3334016B2 (ja) * 1994-07-15 2002-10-15 日研フード株式会社 抗糖尿病活性物質及び抗糖尿病合併症活性物質とその製造方法
DE69633502T2 (de) * 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
JPH09291039A (ja) * 1995-12-26 1997-11-11 Suntory Ltd プロシアニジンを有効成分とする抗肥満剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
JPH11218572A (ja) * 1998-02-04 1999-08-10 Fuji Electric Co Ltd 超音波センサ
JP2000178295A (ja) * 1998-12-17 2000-06-27 Lion Corp 抗腫瘍組成物
FR2790645B1 (fr) * 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
JP2001046030A (ja) * 1999-08-02 2001-02-20 Tama Seikagaku Kk ブルーベリー抽出エキスの製造法
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
WO2001054516A1 (en) * 2000-01-28 2001-08-02 Michigan State University Method for inhibiting a tumor
JP4549486B2 (ja) * 2000-04-26 2010-09-22 アピ株式会社 抗肥満薬及びその製造方法
CA2421109C (en) * 2000-08-31 2011-05-03 Hauser, Inc. Efficient method for producing compositions enriched in anthocyanins

Also Published As

Publication number Publication date
EP1480663A1 (de) 2004-12-01
DE60215866D1 (de) 2006-12-14
US20050084548A1 (en) 2005-04-21
EP1480663B1 (de) 2006-11-02
JP2003252766A (ja) 2003-09-10
AU2002317501A1 (en) 2003-09-09
CA2477555A1 (en) 2003-09-04
WO2003072121A1 (en) 2003-09-04
DE60215866T2 (de) 2007-06-21
ES2274053T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
DE60215866D1 (de) Medikament, enthaltend cyanidin-3-glykosid als wirkstoff gegen fettsucht und diabetes
Krum The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
EP1500400A4 (de) Arzneimittel mit antikörper-zusammensetzung
DK1443974T3 (da) Fremgangsmåde til at producere en steril anordning
DE60115498D1 (de) Chirurgische vorrichtungen
ATE464889T1 (de) Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
BRPI0509573A (pt) derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
ATE543488T1 (de) Medizinische vorrichtungen, bei denen neuepolymere verwendet werden
CY1107752T1 (el) Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης
MXPA05006634A (es) Fluidos de dialisis biocompatibles que contienen icodextrinas.
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
ATE363896T1 (de) Gegen missbrauch gesicherte darreichungsform
DE60214698D1 (de) Implantierbare medizinische vorrichtung und kissenelektrodensystem
DE60336754D1 (de) Enzymbehandlung von nahrungsmitteln für zöliakie-sprue
NO20065195L (no) Terapeutiske enzymformuleringer og anvendelser derav
BRPI0917535A8 (pt) uso de insulina de ação ultra rápida
TR200001892T2 (tr) Monomer cinsi ensülin analogları ve bunların kullanımı.
NO20011174D0 (no) Nye heteroaromatiske inhibitorer av fruktose-1,6-bisfosfotase
BR9814698A (pt) Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase
EP1295609A4 (de) Medikamente mit gemischten aktiven stoffen
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
AR025449A1 (es) Soluciones farmaceuticas de levosimendan
EP1561472A4 (de) Feste zubereitung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties